Eventide Asset Management, LLC Argenx Se Transaction History

Eventide Asset Management, LLC

$5.67 Billion
Q3 2024

A detailed history of Eventide Asset Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Eventide Asset Management, LLC holds 108,189 shares of ARGX stock, worth $68.2 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

108,189

Previous 218,945 50.59%

Holding current value

$68.2 Million

Previous $94.2 Million 37.68%

% of portfolio

1.03%

Previous 1.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $48.1 Million - $61.1 Million	-110,756 Reduced 50.59%	108,189 $58.7 Million
Q2 2024 Aug 13, 2024	BUY	$356.01 - $451.55 $31,328 - $39,736	88 Added 0.04%	218,945 $94.2 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $9.61 Million - $11.1 Million	-26,914 Reduced 10.95%	218,857 $86.2 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $25.6 Million - $38.2 Million	-75,584 Reduced 23.52%	245,771 $93.5 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $2.85 Million - $4.23 Million	-7,721 Reduced 2.35%	321,355 $158 Million
Q2 2023 Aug 15, 2023	BUY	$360.14 - $422.58 $57,622 - $67,612	160 Added 0.05%	329,076 $128 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $16,377 - $19,778	49 Added 0.01%	328,916 $123 Million
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $3.24 Million - $3.81 Million	9,467 Added 2.96%	328,867 $125 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $25.1 Million - $35.3 Million	-93,100 Reduced 22.57%	319,400 $121 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $21.6 Million - $28.1 Million	79,500 Added 23.87%	412,500 $144 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $30.6 Million - $38.1 Million	119,000 Added 55.61%	333,000 $100 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $14.5 Million - $20.5 Million	54,000 Added 33.75%	214,000 $58.9 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $22.4 Million - $28.3 Million	-104,000 Reduced 39.39%	160,000 $42 Million
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $4.24 Million - $7.75 Million	-33,300 Reduced 11.2%	264,000 $59.5 Million
Q4 2019 Jan 29, 2020	BUY	$106.59 - $164.21 $7.17 Million - $11.1 Million	67,300 Added 29.26%	297,300 $47.7 Million
Q3 2019 Nov 21, 2019	BUY	$113.31 - $150.51 $8.72 Million - $11.6 Million	77,000 Added 50.33%	230,000 $26.2 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $9.98 Million - $13.6 Million	-101,000 Reduced 39.76%	153,000 $19.1 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $5.17 Million - $8.9 Million	-81,000 Reduced 24.18%	254,000 $24.4 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $17.7 Million - $22.7 Million	235,000 Added 235.0%	335,000 $25.4 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $5.7 Million - $8.52 Million	100,000 New	100,000 $8.04 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account

Eventide Asset Management, LLC Argenx Se Transaction History